Amy Fisher, MS,CGC
As Patient Advocacy Lead, Ms. Fisher is responsible for building and sustaining relationships with patient advocacy organizations aligned with Spark Therapeutics’ disease areas of interest, including inherited retinal diseases, hemophilia, and certain central nervous system disorders. Ms. Fisher brings nearly two decades experience in rare diseases to her current role, from clinical care in academic medicine to medical affairs and patient advocacy roles in industry. Prior to joining Spark, Ms. Fisher worked in patient advocacy and scientific patient communications at Shire, focusing on Shire’s rare disease portfolio. She also supported Shire medical affairs as a medical science liaison for eastern US territories. Ms. Fisher practiced as a genetic counselor in the Department of Pediatrics, Division of Genetics and Metabolism at the University of North Carolina Chapel Hill, where she counseled patients for a variety of indications, but with a primary focus on inborn errors of metabolism and lysosomal storage disorders.
Ms. Fisher earned a B.S. in Biology (Genetics and Developmental Biology, honors in Biochemistry and Molecular Biology) from Penn State University, and a M.S. in Human Genetics (Genetic Counseling) from the University of Michigan. She is a ABGC board certified genetic counselor.